Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Leukemia & Lymphoma
|
June 28, 2001
First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia
M Clavio, S Gatto, G Beltrami, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 22, 2019
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors
G Marcucci, G Beltrami, A Tamburini, et al.
Experimental Physiology
|
August 31, 2014
Increased blood-oxygen binding affinity in Tibetan and Han Chinese residents at 4200 m
T S Simonson, G Wei, H E Wagner, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 22, 1999
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly
I Pierri, M Clavio, G Beltrami, et al.
Leukemia
|
July 3, 2002
Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT)
T Fischer, C Reifenrath, G R Hess, et al.
Calcified Tissue International
|
April 23, 2015
Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization
L Masi, G Beltrami, S Ottanelli, et al.
European Journal of Haematology
|
September 30, 1998
First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease
M Clavio, M Miglino, M Spriano, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 15, 2003
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients
M Clavio, S Gatto, G Beltrami, et al.
Leukemia Research
|
July 7, 2015
Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes
E Balleari, C Salvetti, L Del Corso, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Leukemia & Lymphoma
|
June 28, 2001
First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia
M Clavio, S Gatto, G Beltrami, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 22, 2019
Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors
G Marcucci, G Beltrami, A Tamburini, et al.
Experimental Physiology
|
August 31, 2014
Increased blood-oxygen binding affinity in Tibetan and Han Chinese residents at 4200 m
T S Simonson, G Wei, H E Wagner, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 22, 1999
GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly
I Pierri, M Clavio, G Beltrami, et al.
Leukemia
|
July 3, 2002
Safety and efficacy of STI-571 (imatinib mesylate) in patients with bcr/abl-positive chronic myelogenous leukemia (CML) after autologous peripheral blood stem cell transplantation (PBSCT)
T Fischer, C Reifenrath, G R Hess, et al.
Calcified Tissue International
|
April 23, 2015
Human Preosteoblastic Cell Culture from a Patient with Severe Tumoral Calcinosis-Hyperphosphatemia Due to a New GALNT3 Gene Mutation: Study of In Vitro Mineralization
L Masi, G Beltrami, S Ottanelli, et al.
European Journal of Haematology
|
September 30, 1998
First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease
M Clavio, M Miglino, M Spriano, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 15, 2003
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients
M Clavio, S Gatto, G Beltrami, et al.
Leukemia Research
|
July 7, 2015
Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes
E Balleari, C Salvetti, L Del Corso, et al.
Page
of 8